 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/22/2024 |
$2.12 |
$2.28 |
$2.12 |
$2.22 |
7.90K | | 04/23/2024 |
$2.15 |
$2.18 |
$2.13 |
$2.13 |
1.60K | | 04/24/2024 |
$2.15 |
$2.20 |
$2.12 |
$2.20 |
12.30K | | 04/25/2024 |
$2.14 |
$2.15 |
$2.08 |
$2.12 |
14.50K | | 04/26/2024 |
$2.08 |
$2.12 |
$2.08 |
$2.11 |
5.60K |
|
|
| PharmaCyte Biotech is a biotechnology company focused on developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®. Co. is developing therapies for solid tumor cancers involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. Co. is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes based upon the encapsulation of a human liver cell line to produce, store and secrete insulin at levels in proportion to the levels of blood sugar in the human body. | |
|
PharmaCyte Biotech (PMCB) has the following price history information. Looking back at PMCB historical stock prices for the last five trading days, on April 22, 2024, PMCB opened at $2.12, traded as high as $2.28 and as low as $2.12, and closed at $2.22. Trading volume was a total of 7.90K shares. On April 23, 2024, PMCB opened at $2.15, traded as high as $2.18 and as low as $2.13, and closed at $2.13. Trading volume was a total of 1.60K shares. On April 24, 2024, PMCB opened at $2.15, traded as high as $2.20 and as low as $2.12, and closed at $2.20. Trading volume was a total of 12.30K shares. On April 25, 2024, PMCB opened at $2.14, traded as high as $2.15 and as low as $2.08, and closed at $2.12. Trading volume was a total of 14.50K shares. On April 26, 2024, PMCB opened at $2.08, traded as high as $2.12 and as low as $2.08, and closed at $2.11. Trading volume was a total of 5.60K shares.
PMCB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into PharmaCyte Biotech shares, starting with a $10,000 purchase of PMCB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/15/2020 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$0.01 |
|
| End price/share: |
$2.11 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
38,974.07% |
|
| Average Annual Total Return: |
490.23% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,907,499.51 |
|
| Years: |
3.36 |
|
|
|
| Date |
Close |
| 04/22/2024 | $2.22 | | 04/23/2024 | $2.13 | | 04/24/2024 | $2.20 | | 04/25/2024 | $2.12 | | 04/26/2024 | $2.11 |
|
|
Free PMCB Email Alerts:
